Skip to main content

Worth Venture Partners, LLC

SEC CIK
0001696778
Latest filing
Aug 10, 2026

PRTK holding history

Paratek Pharmaceuticals, Inc. in every 13F filed by Worth Venture Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PRTK overviewAll 13F holders of PRTKFull Q2 2026 holdings

Shares (Q2 2023)
0
Sold out in Q2 2023
Value
$0
% of portfolio
0.0%
Quarters held
9
Since Q1 2021
Holdings of PRTK by Worth Venture Partners, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20230$00.0%−657,885−100.0%Sold outHolders
Q1 2023657,885$1.67M0.8%−364,590−35.7%ReducedHolders
Q4 20221,022,475$1.91M1.1%+52,777+5.4%AddedHolders
Q3 2022969,698$2.49M1.6%00.0%UnchangedHolders
Q2 2022969,698$2.37M1.4%+185,967+23.7%AddedHolders
Q1 2022783,731$2.33M1.1%+226,899+40.7%AddedHolders
Q4 2021556,832$2.50M1.2%+167,392+43.0%AddedHolders
Q3 2021389,440$1.89M0.9%+158,068+68.3%AddedHolders
Q2 2021231,372$1.58M0.6%+40,279+21.1%AddedHolders
Q1 2021191,093$1.35M0.7%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.